C-peptide and retinal microangiopathy in diabetes

Experimental Diabesity Research

Volumn 5, Issue 1, 2004, Pages 91-96

  Chakrabarti, Subrata ^a   Ali Khan, Zia ^a   Cukiernik, Mark ^a   Zhang, Weixian ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Basement membrane; C peptide; Diabetes; Fibronectin; Oncofetal fibronectin; Retina

Indexed keywords

C PEPTIDE; ENDOTHELIN 1; FIBRONECTIN; GLUCOSE; MESSENGER RNA; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD GLUCOSE MONITORING; CAPILLARY BASEMENT MEMBRANE; CELL CULTURE; CELL LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DRUG MECHANISM; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC VARIABILITY; HISTOPATHOLOGY; MALE; MEMBRANE COMPONENT; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; RETINA CAPILLARY; REVIEW; RNA SPLICING; SURGICAL TECHNIQUE; ULTRASTRUCTURE; UPREGULATION;

ANIMALS; BASEMENT MEMBRANE; C-PEPTIDE; CAPILLARIES; DIABETIC RETINOPATHY; ENDOTHELIN-1; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HUMANS; RETINAL VESSELS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 1842741097     PISSN: 15438600     EISSN: None     Source Type: Journal    
DOI: 10.1080/15438600490424569     Document Type: Review

References (41)

1. Badylak, S. F. (2002) The extracellular matrix as a scaffold for tissue reconstruction. Semin. Cell Dev. Biol., 13, 377-383.
2. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
3. Cai, J., and Boulton, M. (2002) The pathogenesis of diabetic retinopathy: Old concepts and new questions. Eye, 16, 242-260.
4. Cameron, N. E., Eaton, S. E., Cotter, M. A., and Tesfaye, S. (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia, 44, 1973-1988.
5. Carnemolla, B., Balza, E., Siri, A., Zardi, L., Nicotra, M. R., Bigotti, A., and Natali, P. G. (1989) A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol., 108, 1139-1148.
6. Chen, S., Khan, Z. A., Cukiernik, M., and Chakrabarti, S. (2003) Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am. J. Physiol. Endocrinol. Metab., 284, E1089-E1097.
7. Evans, T., Deng, D. X., Chen, S., and Chakrabarti, S. (2000) Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes, 49, 662-666.
8. Flatt, P. R., Swanston-Flatt, S. K., Hampton, S. M.. Bailey, C. J., and Marks, V. (1986) Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci. Rep., 6, 193-199.
9. Grunberger, G., Qiang, X., Li, Z., Mathews, S. T., Sbrissa, D., Shisheva, A., and Sima, A. A. F. (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia, 44, 1247-1257.
10. Henriksson, M., Pramanik, A., Shafqat, J., Zhong, Z., Tally, M., Ekberg, K., Wahren, J., Rigler, R., Johansson, J., and Jörnvall, H. (2001) Specific binding of proinsulin C-peptide to intact and to detergent-solubilized human skin fibroblasts. Biochem. Biophys. Res. Commun., 280, 423-427.
11. Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W. F., DiMarchi, R. D., Di Cera, E., and Williamson, J. R. (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science, 277, 563-566.
12. Jarnagin, W. R., Rockey, D. C., Koteliansky, V. E., Wang, S. S., and Bissell, D. M. (1994) Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J. Cell Biol., 127, 2037-2048.
13. Johansson, J., Ekberg, K., Shafqat, J., Henriksson, M., Chibalin, A., Wahren, J., and Jörnvall, H. (2002) Molecular effects of proinsulin C-peptide. Biochem. Biophys. Res. Commun., 295, 1035-1040.
14. Johansson, B. L., Sjöberg, S., and Wahren, J. (1992) The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia, 35, 121-128.
15. Keen, H., Lee, E. T., Russell, D., Miki, E., Bennett, P. H., and Lu, M. (2001) The appearance of retinopathy and progression to proliferative retinopathy: The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia, 44 (Suppl), S22-S30.
16. Khan, Z. A., Cukiernik, M., Gonder, J. R., and Chakrabarti, S. (2004) Oncofetal fibronectin in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 45, 287-295.
17. Kitabchi, A. E. (1977) Proinsulin and C-peptide: A review. Metabolism, 26, 547-587.
18. Kitamura, T., Kimura, K., Jung, B. D., Makondo, K., Okamoto, S., Canas, X., Sakane, N., Yoshida, T., and Saito, M. (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: Requirement of protein kinase C, phospho-inositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem. J., 355, 123-129.
19. Kitamura, T., Kimura, K., Makondo, K., Furuya, D. T., Suzuki, M., Yoshida, T., and Saito, M. (2003) Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia, 46, 1698-1705, online, 30 Oct., 2003.
20. Kornblihtt, A. R., Pesce, C. G., Alonso, C. R., Cramer, P., Srebrow, A., Werbajh, S., and Muro, A. F. (1996) The fibronectin gene as a model for splicing and transcription studies. FASEB J., 10, 248-257.
21. Kornblihtt, A. R., Vibe-Pedersen, K., and Baralle, F. E. (1984) Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J., 3, 221-226.
22. Li, Z. G., Qiang, X., Sima, A. A., and Grunberger, G. (2001) C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem. Biophys. Res. Commun., 280, 615-619.
23. Li, Z. G., Zhang, W., and Sima, A. A. (2003) C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab Res. Rev., 19, 375-385.
24. Nickeleit, V., Kaufman, A. H., Zagachin, L., Dutt, J. E., Foster, C. S., and Colvin, R. B. (1996) Healing corneas express embryonic fibronectin isoforms in the epithelium, subepithelial stroma, and endothelium. Am. J. Pathol., 149, 549-558.
25. +, K(+)-ATPase activity in synergism with neuropeptide Y. Diabetologia, 39, 199-205.
26. Pierson, C. R., Zhang, W., and Sima, A. A. F. (2003) Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J. Neuropathol. Exp. Neurol., 62, 765-779.
27. Pramanik, A., Ekberg, K., Zhong, Z., Shafqat, J., Henriksson, M., Jansson, O., Tibell, A., Tally, M., Wahren, J., Jörnvall, H., Rigler, R., and Johansson, J. (2001) C-peptide binding to human cell membranes: importance of Glu27. Biochem. Biophys. Res. Commun., 284, 94-98.
28. Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O. T., Nygren, R, Ståhl, S., Ekberg, K., Johansson, B., Uhlén, S., Uhlén, M., Jörnvall, H., and Wahren, J. (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc. Natl. Acad. Sci. U. S. A., 96, 13318-13323.
29. Roy, S., Cagliero, E., and Lorenzi, M. (1996) Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest. Ophthalmol. Vis. Sci., 37, 258-266.
30. Samnegard, B., Jacobson, S. H., Jaremko, G., Johansson, B. L., and Sjöquist, M. (2001) Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int., 60, 1258-1265.
31. Schwarzbauer, J. E., Tamkun, J. W., Lemischka, I. R., and Hynes, R. O. (1983) Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell, 35, 421-431.
32. 2+ increases in human renal tubular cells. Cell Mol. Life Sci., 59, 1185-1189.
33. Sheetz, M. J., and King, G. L. (2002) Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA, 288,2 579-2588.
34. Sima, A. A. (2003) C-peptide and diabetic neuropathy. Expert. Opin. Inves. Drugs, 12, 1471-1488.
35. Sima, A. A., Zhang, W., Sugimoto, K., Henry, D., Li, Z., Wahren, J., and Grunberger, G. (2001) C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB/Wor-rat. Diabetologia, 44, 889-897.
36. Sjöquist, M., Huang, W., and Johansson, B. L. (1998) Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int., 54, 758-764.
37. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med., 329, 977-986.
38. Tsilibary, E. C. (2003) Microvascular basement membranes in diabetes mellitus. J. Pathol., 200, 537-546.
39. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352, 837-853.
40. Wahren, J., Ekberg, K., Johansson, J., Henriksson, M., Pramanik, A., Johansson, B. L., Rigler, R., and Jörnvall, H. (2000) Role of C-peptide in human physiology. Am. J. Physiol. Endocrinol. Metab., 278, E759-E768.
41. Zardi, L., Carnemolla, B., Siri, A., Petersen, T. E., Paolella, G., Sebastio, G., and Baralle, F. E. (1987) Transformed human cells produce a new fibronectin isofortn by preferential alternative splicing of a previously unobserved exon. EMBO J., 6, 2337-2342.